PEAK Surgical Announces Completion of First PRECISE Clinical Study, Receipt of Medical Design Excellence Award for PEAK(R) Surgery System and Achievement of Over 1,000 Surgeries Using PEAK Plasm... (/b For decades surgeons have relied o...)

HOME >> MEDICINE >> TECHNOLOGY

PEAK Surgical Announces Completion of First PRECISE Clinical Study, Receipt of Medical Design Excellence Award for PEAK(R) Surgery System and Achievement of Over 1,000 Surgeries Using PEAK PlasmaBlade(TM)

Date:4/7/2009

/b>

For decades, surgeons have relied on scalpels to cut skin and delicate tissues and have used electrosurgical devices to cut and coagulate fat and other thicker, tougher tissues. Although scalpels precisely cut tissue, they do not control bleeding. Electrosurgical devices, on the other hand, cut efficiently and control bleeding but cause extensive thermal damage to surrounding tissue. In cases where the risk of collateral damage or scarring from electrosurgery is considered to be unacceptable, surgeons must use both a traditional scalpel for cutting and an electrosurgical device for coagulation.

The PlasmaBlade family of devices offers the precision of a scalpel and the bleeding control of a traditional electrosurgery device in a single surgical instrument. The PlasmaBlade family includes the PlasmaBlade 4.0, which is designed to be used to cut through all types of soft tissue, including skin, fat and muscle; the PlasmaBlade Needle, which has a fine needlepoint tip and is specifically designed for ultra-precise surgical procedures; and the PlasmaBlade EXT, which is designed for use in surgical procedures requiring an extended-reach tip.

Unlike most radiofrequency-based surgical products that use continuous voltage waveforms to cut tissue, the PULSAR Generator supplies pulsed plasma radiofrequency energy to the PlasmaBlade to incise tissue and control bleeding. Because the radiofrequency energy is provided through short on-and-off pulses via a highly insulated cutting electrode, the PlasmaBlade cuts at half the average temperature of a conventional electrosurgery device and can be as low as 50 degrees Centigrade. This temperature reduction results in significantly less damage to surrounding tissues compared to traditional electrosurgery. The PlasmaBlade is also able to dissect tissue in a completely submerged surgical field, another shortcoming of traditional electrosurgical devices.

Preclinical results ha
'/>"/>

SOURCE PEAK Surgical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Innocoll Announces Dosing of Last Patient in Second US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Colorectal Surgery Patients
2. Innocoll Announces Dosing of Last Patient in US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Cardiac Surgery Patients
3. Children and Orthopaedic Surgical Emergencies
4. Novel Product for Post Surgical Scar Formation Entering Clinical Development
5. ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease
6. PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications
7. News Media Advisory: Worlds Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments
8. American Heart Association Journal Report: Surgical Residents Perform Heart Surgery as Effectively as Staff Surgeons
9. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) Needle
10. Morse CyberKnife CEO James G. Schwade, M.D. Announces Non-Surgical Treatment With CyberKnife Radiosurgery for Prostate Cancer
11. Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain

Post Your Comments:

(Date:12/16/2009)... 16 Today, Avantium announced the,appointment ... of its pharmaceutical,business. Gunnar Staaf previously worked ... Lilly & Company, in a range of ... important step in Avantium,s plan to,spin-out its ... a,stand-alone pharmaceutical company based on its offering ...

(Date:12/16/2009)... Lower Prescription Drug Prices ,, CHICAGO, Dec. ... night rejected an amendment to the Patient Protection ... prescription drugs more affordable by allowing for the ... from abroad. The bipartisan amendment, endorsed by ... Grassley and Stabenow, would have improved competition and ...

(Date:12/16/2009)... Dec. 16 Frost & Sullivan,s ... looks forward to speaking at the 2010 ... place on January 9, 2010 in Las ... emerging market of consumer-based digital health and ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) ,, Bujnoch focuses ...

Breaking Medicine Technology:Avantium Appoints Gunnar Staaf as CEO Pharma 2 AARP Illinois Key Vote News Alert 2 Frost & Sullivan to Speak at 2010 International Consumer Electronics Digital Health Summit 2 FDA Approves Lysteda to Treat Heavy Menstrual Bleeding 6264 1 FDA Approves Lysteda to Treat Heavy Menstrual Bleeding 6264 2 Facial Structure May Hold Clues to Aggression 61341 1 Donna H Ryan M D Elected President of The Obesity Society for 2009 2010 61336 1 Donna H Ryan M D Elected President of The Obesity Society for 2009 2010 61336 2 Donna H Ryan M D Elected President of The Obesity Society for 2009 2010 61336 3

[0] Avantium Appoints Gunnar Staaf as CEO Pharma [0] AARP Illinois Key Vote News Alert [0] Frost & Sullivan to Speak at 2010 International Consumer Electronics Digital Health Summit

... ASCO MeetingINDIANAPOLIS, May 30 Semafore Pharmaceuticals, Inc., ... company, today presented data from a Phase I ... SF1126, at the 2009 American Society of Clinical ... Florida.Dr. E. Gabriela Chiorean, from the Indiana ...

... 29 The American Society of Clinical ... research conducted at the Barbara Ann Karmanos ... ASCO,s Web site. Karmanos, potentially ground-breaking findings ... aggressive hormone receptor negative breast cancer tumors.(Logo: ...

Other Medicine Technology:Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients 2 Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients 3 Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy 2 Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy 3

Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy

(Date:12/16/2009)... has been found, , , WEDNESDAY, Dec. 16 (HealthDay News) ... to food poisoning and the stomach pain and diarrhea ... some urinary tract infections. , Researchers have found the ... and restaurants and in women with the infections. ... directly to the women through the food they ate, ...

(Date:12/16/2009)... Age should not be determining factor for use, expert ... people with heart failure are much less likely to ... a new study. , The study included 4,685 people, ... device and had a left ventricular fraction (a measure ... less. , During a three-year period, those who were ...

(Date:12/16/2009)... OrthoAccel Technologies, Inc., developers of the ... device to enhance orthodontics, announced Alison Davies as ... Ms. Davies has spent the last fourteen ... industry, most recently for nine years as a ... of Invisalign . ,, (Logo: ...

(Date:12/16/2009)... Retirement Services Division has announced plans to introduce ... 2010. The new platform will include a full ... in a variety of themes. Plan sponsors will ... of creative options to support the theme best ... RetireSmart participant engagement platform will be phased in ...

(Date:12/16/2009)... diagnostic procedures in cardiology. The idea of publishing an ... of European cardiovascular imagers, is therefore long awaited. The ... with a patient rather than technology-based approach, helping clinicians ... aid of imaging. , The book is divided ... practice of cardiac imaging and its clinical use in ...

Breaking Medicine News(10 mins):Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 2 Health News:Foodborne E. Coli Suspected in Urinary Tract Infections 3 Health News:Implanted Defibrillator Might Extend Life 2 Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 2 Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 3 Health News:Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom 4 Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 2 Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 3 Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 4 Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 5 Health News:The European Society of Cardiology Textbook of Cardiovascular Imaging puts patient at center 2 Health News:The European Society of Cardiology Textbook of Cardiovascular Imaging puts patient at center 3

[0] Foodborne E. Coli Suspected in Urinary Tract Infections [0] Implanted Defibrillator Might Extend Life [0] Top-performing Sales Manager Joins OrthoAccel Technologies, Inc. in the United Kingdom [0] MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform [0] The European Society of Cardiology Textbook of Cardiovascular Imaging puts patient at center

... earnings per share of $0.89, up 24%- Total revenues ... of $273 million, up 73%- 2009 EPS outlook increased ... Quest Diagnostics Incorporated (NYSE: DGX ), the ... announced that for the first quarter ended March 31, ...

... enhanced RadarFind RTLS , ... Morrisville, NC (PRWEB) April ... healthcare system in North Carolina,s Triangle region, has launched the ... Hospital location. After serving as a development partner since April 2008, ...

... Company Delivers Solid Financial Performance, Continues to Advance ... Corporation (NYSE: SGP ) today reported ... powered through to deliver a solid performance in ... CEO. "We overcame difficult currency comparisons and ...

... pharmaceutical companies find, evaluate and manage drug partners ... drug development lifecycleSAN FRANCISCO, April 21 ... partnering site for the pharmaceutical development and drug ... website, goBalto.com. goBalto transforms the way drug-development partners ...

... DEL MAR, Calif., April 21 Patient Safety Week ... automated blood pressure device (1979), the pulse oximeter (1983) ... personal financial profit. All of these technological devices clearly ... Dr. Barry Friedberg as a forward thinking, caring physician."Until ...

... Surgeons study indicating that 98% of breast cancer patients are satisfied ... surgeon , Dr. Bob Basu explains why breast reconstruction following a ... ... Houston TX (Vocus) April 21, 2009 -- The American Society ...

Quest Diagnostics Reports Strong Earnings Growth In First Quarter 2009 WakeMed Shares Best Practices for Tracking Assets, Patients Schering-Plough Reports Financial Results for 2009 First Quarter Contract Drug Development Resource, goBalto, Launches New Web-Based Platform, goBalto.com American Society of Anesthesiologists Recent Public Debate Comes to Dead End Houston Plastic Surgeon Cites ‘Therapeutic' Benefits for Women that Choose Breast Reconstruction After Mastectomy

... Novus Spectra photocoagulator delivers power and ... solid-state (DPSS) technology. Diode side-pumping technology ... the compact Novus Spectra system, and ... beam output and system reliability from ...

Features soft, low friction sheath that extends beyond the tip....

Designed to retain the desired curve during oral intubation....

Facilitates intubation of tracheal tubes....

Medicine Products:

Novus Spectra Photocoagulator SHERIDAN SOFT-TIP® 10Fr Intubating Stylet SHERIDAN SHER-I-SLIP® 10Fr Intubating Stylet Satin-Slip® 6FR Intubating Stylet

PEAK Surgical Announces Completion of First PRECISE Clinical Study, Receipt of Medical Design Excellence Award for PEAK(R) Surgery System and Achievement of Over 1,000 Surgeries Using PEAK Plasm...(/b For decades surgeons have relied o...),Health